Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane.
Shah SK, Chen N, Guthikonda RN, Mills SG, Malkowitz L, Springer MS, Gould SL, Demartino JA, Carella A, Carver G, Holmes K, Schleif WA, Danzeisen R, Hazuda D, Kessler J, Lineberger J, Miller M, Emini EA, MacCoss M.
Shah SK, et al. Among authors: guthikonda rn.
Bioorg Med Chem Lett. 2005 Feb 15;15(4):977-82. doi: 10.1016/j.bmcl.2004.12.044.
Bioorg Med Chem Lett. 2005.
PMID: 15686896